Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
7.25
+0.21 (2.98%)
At close: Jun 18, 2026, 4:00 PM EDT
7.29
+0.04 (0.55%)
After-hours: Jun 18, 2026, 4:10 PM EDT
Burning Rock Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 446 | 478.39 | 519.85 | 615.1 | 905.45 | 1,431 |
Short-Term Investments | - | - | - | - | - | 63.76 |
Cash & Short-Term Investments | 446 | 478.39 | 519.85 | 615.1 | 905.45 | 1,495 |
Cash Growth | -9.93% | -7.98% | -15.48% | -32.07% | -39.44% | -33.77% |
Accounts Receivable | 177.21 | 181.91 | 165.87 | 149.61 | 151.71 | 134.59 |
Inventory | 54.29 | 48.58 | 62.63 | 69.02 | 130.32 | 123.21 |
Other Current Assets | 23.49 | 29.71 | 28.28 | 50.37 | 71.28 | 68.07 |
Total Current Assets | 701 | 738.59 | 776.62 | 884.1 | 1,259 | 1,821 |
Net Property, Plant & Equipment | 78.93 | 73.87 | 100.34 | 144.2 | 300.03 | 406.45 |
Other Intangible Assets | 0.26 | 0.28 | 0.42 | 0.96 | 1.99 | 5.15 |
Long-Term Investments | - | - | - | 5.66 | 5.8 | 0.91 |
Other Long-Term Assets | 7.6 | 7.63 | 7.93 | 5.09 | 20.89 | 45.14 |
Total Assets | 787.78 | 820.38 | 885.31 | 1,040 | 1,587 | 2,279 |
Accounts Payable | 18.04 | 40.74 | 33.75 | 18.06 | 50.95 | 63.08 |
Accrued Expenses | 75.38 | 80.86 | 89.5 | 104.94 | 173.83 | 127.89 |
Short-Term Debt | - | - | - | - | - | 2.37 |
Current Portion of Long-Term Debt | 0.2 | 0.2 | - | - | - | - |
Current Portion of Leases | 21.11 | 16.76 | 24.57 | 8.63 | 37.24 | 35 |
Unearned Revenue | 114.49 | 107.82 | 117.9 | 130.54 | 147.63 | 142.87 |
Other Current Liabilities | 0.59 | 0.59 | 0.59 | 1.2 | 1.8 | 0.97 |
Total Current Liabilities | 229.82 | 246.98 | 266.3 | 263.36 | 411.45 | 372.18 |
Long-Term Debt | 1.7 | 1.7 | - | - | - | - |
Long-Term Leases | 27.85 | 24.46 | 27.75 | 3.69 | 13.55 | 49.32 |
Other Long-Term Liabilities | 11.96 | 11.98 | 10.43 | 4.54 | 4.12 | 11.78 |
Total Long-Term Liabilities | 41.51 | 38.13 | 38.18 | 8.23 | 17.68 | 61.09 |
Total Liabilities | 271.33 | 285.11 | 304.48 | 271.59 | 429.13 | 433.28 |
Common Stock | 0.14 | 0.14 | 0.15 | 0.14 | 0.14 | 0.14 |
Treasury Stock | -57.19 | -57.19 | -63.26 | -65.9 | -58.92 | - |
Additional Paid-in Capital | 5,012 | 5,010 | 5,002 | 4,849 | 4,583 | 4,281 |
Accumulated Other Comprehensive Income | -165.28 | -162.14 | -158.05 | -161.53 | -165.72 | -207.07 |
Retained Earnings | -4,273 | -4,256 | -4,200 | -3,854 | -3,200 | -2,229 |
Shareholders' Equity | 516.46 | 535.26 | 580.83 | 768.41 | 1,158 | 1,845 |
Total Liabilities & Equity | 787.78 | 820.38 | 885.31 | 1,040 | 1,587 | 2,279 |
Total Debt | 50.86 | 43.12 | 52.32 | 12.32 | 50.79 | 86.69 |
Net Cash (Debt) | 395.14 | 435.27 | 467.53 | 602.77 | 854.66 | 1,408 |
Net Cash Growth | -9.22% | -6.90% | -22.44% | -29.47% | -39.32% | -36.29% |
Net Cash Per Share | 38.71 | 41.38 | 43.45 | 58.84 | 83.27 | 133.99 |
Book Value | 516.46 | 535.26 | 580.83 | 768.41 | 1,158 | 1,845 |
Book Value Per Share | 50.60 | 50.89 | 53.97 | 75.01 | 112.85 | 175.56 |
Tangible Book Value | 516.2 | 534.98 | 580.41 | 767.45 | 1,156 | 1,840 |
Tangible Book Value Per Share | 50.57 | 50.86 | 53.93 | 74.92 | 112.66 | 175.07 |